Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-84,208
Closed -$827K 3480
2025
Q2
$827K Buy
84,208
+14,488
+21% +$120K ﹤0.01% 2268
2025
Q1
$507K Buy
+69,720
New +$610K ﹤0.01% 2276
2024
Q4
Sell
-46,617
Closed -$345K 3151
2024
Q3
$345K Buy
+46,617
New +$392K ﹤0.01% 2237
2024
Q2
Sell
-47,630
Closed -$554K 2454
2024
Q1
$554K Buy
+47,630
New +$527K ﹤0.01% 1609
2023
Q3
Sell
-27,470
Closed -$521K 2441
2023
Q2
$521K Buy
+27,470
New +$482K 0.01% 1688
2023
Q1
Sell
-11,142
Closed -$142K 2570
2022
Q4
$142K Buy
+11,142
New +$100K ﹤0.01% 2184

Other funds holding ETNB

Tudor Investment Corp's ETNB Position: Q3 2025 in Review

Tudor Investment Corp sold out of 89bio (ETNB) in Q3 2025, closing a stake of 84,208 shares — an estimated $827K sold.

Tudor Investment Corp first reported a position in ETNB in Q4 2022 and held it in 6 quarters. The position peaked at $827K in Q2 2025. 198 funds tracked by Wall St. Rank hold ETNB as of Q3 2025.

  • Tudor Investment Corp reported no remaining 89bio position as of Q3 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 84,208 89bio shares in Q3 2025, an estimated $827K.
  • Tudor Investment Corp first reported a position in 89bio in Q4 2022 and held it in 6 quarters.
  • Tudor Investment Corp's 89bio position peaked at $827K in Q2 2025.
  • 198 funds tracked by Wall St. Rank held 89bio as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.